or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    JNJ B 0.89 3.21
    PRU C 1.26 2.72
    GDDY D -1.30 2.60
    TRV A 1.86 2.57
    PEP B -0.08 2.50
    AMP B 1.08 2.50
    BK A 2.66 2.43
    ABBV B 0.78 2.33
    KMB C 0.47 2.13
    MPC F -1.57 2.09

    Represented by ETF Holdings

    Keywords: S&P 500 Financial Products Infection Insurance Retail Outlets Annuity Products Disability Dow Jones Component Fixed Annuity Infection Prevention Infection Prevention Products Investment Management Pain Management Riversource Variable And Fixed Annuity Products Adalimumab Advanced Prostate Cancer Advisory Services Anemia Annuities
    Industries: Asset Management Drug Manufacturers - Major Beverages - Soft Drinks Household & Personal Products Insurance - Life Insurance - Property & Casualty Internet Content & Information Oil & Gas Refining & Marketing

    Recent News for Federated Hermes ETF Trust Federated Hermes MDT Large Cap Value ETF & its Holdings

    Date Stock Title
    Sep 16 KMB ADRNY or KMB: Which Is the Better Value Stock Right Now?
    Sep 16 MPC Marathon Petroleum: A Solid Oil Refiner Despite Sector Weakness
    Sep 16 MPC Navigating 8 Analyst Ratings For Marathon Petroleum
    Sep 16 JNJ J&J’s Shockwave strengths IVL grasp with new US catheter launch
    Sep 16 TRV Here's Why Travelers (TRV) is a Strong Momentum Stock
    Sep 16 TRV Travelers Schedules Conference Call to Review Third Quarter 2024 Results
    Sep 16 ABBV Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
    Sep 16 PEP Jim Cramer on Celsius Holdings Inc. (CELH): ‘I Don’t Trust It’
    Sep 16 JNJ Johnson & Johnson’s RYBREVANT trial shows improved response rate
    Sep 16 BK The Bank of New York Mellon to launch Alts Bridge
    Sep 16 BK BNY to Launch Alts Bridge Platform Broadening Investor Access to Alternative Products
    Sep 16 JNJ Neoadjuvant TAR-200 plus cetrelimab nearly doubles the pathological complete response rate compared to cetrelimab alone in patients with muscle-invasive bladder cancer
    Sep 15 GDDY Why Jim Cramer Likes GoDaddy Inc. (GDDY) After Its Recent Dip
    Sep 15 PRU Why I Just Loaded Up on This Dirt Cheap High-Yield Dividend Stock
    Sep 15 JNJ New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
    Sep 14 JNJ J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report
    Sep 14 PEP PepsiCo, Inc. (PEP): One of the Best Stocks for Beginners with Little Money
    Sep 14 JNJ Is Johnson & Johnson (JNJ) the Best Blue Chip Stock To Invest In According to Short Sellers?
    Sep 14 JNJ RYBREVANT® (amivantamab-vmjw) plus chemotherapy show 49 percent overall response rate in metastatic colorectal cancer
    Sep 14 ABBV Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
    The fund seeks to achieve its objective by investing primarily in the common stock of large-cap U.S. companies undervalued relative to the market. It will invest its assets so that at least 80% of its net assets (plus any borrowings for investment purposes) are invested in a mix of large-cap and value investments. The fund manager actively trades its portfolio securities in an attempt to achieve its investment objective.
    Index Fund Private Equity Investment Management Stock Fund
    Back to the Main FLCV Page...